EP2913343
AND-IL7 mótefni
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
20.12.2006EP published:
8.8.2018EP application number:
14186905.7
EP translation filed:
2.11.2018Grant published:
15.12.2018EPO information:
European Patent Register
Max expiry date:
19.12.2026Expiry date:
19.12.2026
Title:
Anti-ILT7 antibody
Timeline
Today
20.12.2006EP application
8.8.2018EP Publication
2.11.2018Translation submitted
15.12.2018Registration published
19.12.2026Expires
Owner
Name:
SBI Biotech Co., Ltd.Address:
1-6-1, Roppongi, 106-6018, Minato-ku , Tokyo, JP
Inventor
Name:
Kamogawa, YumikoAddress:
Tokyo, JP
Name:
Cho, MinkwonAddress:
Tokyo, JP
Name:
Arai, NaokoAddress:
Tokyo, JP
Name:
Ishida, KojiAddress:
Tokyo, JP
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
2005366465Date:
20.12.2005Country:
JP
Classification
Categories:
C07K 16/28, A61K 39/395, G01N 33/569, C12N 5/00, G01N 33/577, G01N 33/566, G01N 33/68, A61P 37/00, A61K 39/00
Annual fees
Number
Paid
Expires
Payer
Number: 13
Paid: 25.2.2019
Expires: 19.12.2019
Payer: Árnason Faktor
Number: 14
Paid: 7.11.2019
Expires: 19.12.2020
Payer: Árnason Faktor
Number: 15
Paid: 6.11.2020
Expires: 19.12.2021
Payer: Árnason Faktor ehf.
Number: 16
Paid: 8.11.2021
Expires: 19.12.2022
Payer: Árnason Faktor ehf.
Number: 17
Paid: 9.11.2022
Expires: 19.12.2023
Payer: Árnason Faktor ehf.
Number: 18
Paid: 1.11.2023
Expires: 19.12.2024
Payer: Maxval Group, Inc.
Number: 19
Paid: 28.11.2024
Expires: 19.12.2025
Payer: Árnason Faktor ehf.
Number: 20
Paid: 15.12.2025
Expires: 19.12.2026
Payer: Árnason Faktor ehf.